Enosi Therapeutics

07/31/2023

The story of Enosi is essentially the evolution of our founders' groundbreaking discoveries.

Dr. H. Michael Shepard's identification of the HER2 gene/invention of Herceptin and Sir Marc Feldmann's development of anti-TNF monoclonal antibodies in treating RA.

Founder Research Publications Lasker Award Winner Shepard Describes Herceptin Discovery In this article, Lasker Award-winner Dr. H. Michael Shepard describes leading the team that identified the deadly HER2 gene’s role in the development of breast cancer; and the invention of, “Herceptin” to b...

07/24/2023

"The most common cancer types trending upward were breast, colorectal, uterine, kidney, and thyroid cancers among women, and colorectal, kidney, liver, prostate, and thyroid cancers among men."

Much more research is needed but trends continue to concern 🧬

A rise in cancer rates among younger people is worrying and puzzling doctors.

07/20/2023

Not only is the cancer drug shortage affecting patients, it’s causing severe hinderances in the world of cancer research 🔬

The United States is in the midst of some of the worst cancer drug shortages in history, affecting thousands of patients across the country who face delayed or cancelled chemotherapy appointments. But these shortages aren’t just bad for current patients, experts say; their effects on cancer resear...

07/13/2023

Great background on Immunotherapy for cancer for those interested in what Enosi and companies like us are working on 🔬🧬

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.

07/11/2023

We're hopeful that more studies like these dedicated to oft underrepresented ethnic groups will bring about a balancing of the scales as it relates to advanced breast cancer at diagnosis when compared to their white counterparts🧬

A new Cancer Research UK-funded study aims to shed light on the variation in breast cancer across different ethnic minority groups.

07/06/2023

As we spend more time in the sun this summer, it’s a great time to boost our sun safety IQ 🧠

Sun safety is not just for vacation. Are you sun-safe every day? Take the American Cancer Society's quiz and find out.

06/28/2023

Big things happening in the Windy City.

Chicago's first freestanding cancer care and research facility was approved - to make great progress you need great support.

Congrats to UChicago Medicine!

The University of Chicago Medicine gets state regulatory approval to build the city's first freestanding facility dedicated to cancer prevention, care and research.

06/23/2023

This is a big deal. Countless doctors and researchers including our own Co-Founder and CEO, Dr. H. Michael Shepard contributed to this remarkable rise in the breast cancer survival rate

Women diagnosed since 2010 have a much lower risk of dying than those diagnosed in the 1990s.

06/20/2023

Another example of an immunotherapy breaking through in cancert treatment. This time paired with chemo in patients with advanced non–small cell lung cancer 🧬

Frontline chemoimmunotherapy was associated with improved median overall survival, compared with chemotherapy alone, in patients with advanced non–small cell lung cancer.

06/15/2023

More news continues to come out on the "early on-set cancer epidemic".

This nearly 18% increase in cases (2000-2019) is yet another reason to get screened and live a healthy lifestyle - at any age.

Vanessa Chapoy had just turned 24 when she felt the lump in her breast. It was “huge,” she remembers, “like the size of a walnut, or a big marble.” She went to the first in a series of doctors that…

06/12/2023

During (June 11-18), we recognize gender-specific cancers like prostate, testicular, pe**le and the need to screen for and prevent them 🧬

**lecancer

06/08/2023

You've probably read about drug shortages affecting patients and many of those drugs are cancer treatments 💊

As many as 100,000 patients may have been affected by certain cancer drug scarcities.

One woman denied a chemotherapy drug compares the situation to "triage on the battlefield".